2OFU
x-ray crystal structure of 2-aminopyrimidine carbamate 43 bound to Lck
2OFU の概要
| エントリーDOI | 10.2210/pdb2ofu/pdb |
| 分子名称 | Proto-oncogene tyrosine-protein kinase LCK, SULFATE ION, 2,6-DIMETHYLPHENYL 2-(3,5-DIMETHOXY-4-(3-(4-METHYLPIPERAZIN-1-YL)PROPOXY)PHENYLAMINO)PYRIMIDIN- 4-YL(2,4-DIMETHOXYPHENYL)CARBAMATE, ... (4 entities in total) |
| 機能のキーワード | lck, kinase domain, transferase |
| 由来する生物種 | Homo sapiens (human) |
| 細胞内の位置 | Cytoplasm: P06239 |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 32433.97 |
| 構造登録者 | |
| 主引用文献 | Martin, M.W.,Newcomb, J.,Nunes, J.J.,McGowan, D.C.,Armistead, D.M.,Boucher, C.,Buchanan, J.L.,Buckner, W.,Chai, L.,Elbaum, D.,Epstein, L.F.,Faust, T.,Flynn, S.,Gallant, P.,Gore, A.,Gu, Y.,Hsieh, F.,Huang, X.,Lee, J.H.,Metz, D.,Middleton, S.,Mohn, D.,Morgenstern, K.,Morrison, M.J.,Novak, P.M.,Oliveira-dos-Santos, A.,Powers, D.,Rose, P.,Schneider, S.,Sell, S.,Tudor, Y.,Turci, S.M.,Welcher, A.A.,White, R.D.,Zack, D.,Zhao, H.,Zhu, L.,Zhu, X.,Ghiron, C.,Amouzegh, P.,Ermann, M.,Jenkins, J.,Johnston, D.,Napier, S.,Power, E. Novel 2-Aminopyrimidine Carbamates as Potent and Orally Active Inhibitors of Lck: Synthesis, SAR, and in Vivo Antiinflammatory Activity J.Med.Chem., 49:4981-, 2006 Cited by PubMed Abstract: The lymphocyte-specific kinase (Lck) is a cytoplasmic tyrosine kinase of the Src family expressed in T cells and NK cells. Genetic evidence in both mice and humans demonstrates that Lck kinase activity is critical for signaling mediated by the T cell receptor (TCR), which leads to normal T cell development and activation. A small molecule inhibitor of Lck is expected to be useful in the treatment of T cell-mediated autoimmune and inflammatory disorders and/or organ transplant rejection. In this paper, we describe the synthesis, structure-activity relationships, and pharmacological characterization of 2-aminopyrimidine carbamates, a new class of compounds with potent and selective inhibition of Lck. The most promising compound of this series, 2,6-dimethylphenyl 2-((3,5-bis(methyloxy)-4-((3-(4-methyl-1-piperazinyl)propyl)oxy)phenyl)amino)-4-pyrimidinyl(2,4-bis(methyloxy)phenyl)carbamate (43) exhibits good activity when evaluated in in vitro assays and in an in vivo model of T cell activation. PubMed: 16884310DOI: 10.1021/jm060435i 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






